How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

At 39, Leslie Kenny was diagnosed with rheumatoid arthritis and lupus and says she was told she had around five years to live. More than two decades later, she is in long-term remission and has turned that experience into a mission: helping patients become better informed, more involved and more confident in decisions about their own health.

In this episode, Leslie Kenny, founder of Oxford Healthspan and co-founder of the Oxford Longevity Project, joins Daphna Stern to tell the story of how she challenged her original prognosis, found intravenous immunoglobulin (IVIG) through her own research, changed her diet and ultimately reached remission.

But her story also raises a much bigger question: where should patient empowerment end and medical expertise begin?

The conversation then turns to spermidine, a naturally occurring compound found in the body and in foods that has attracted growing interest for its relationship with autophagy — the cellular recycling process that helps remove and reuse damaged cellular material. Leslie explains why she became convinced of its potential and why she believes natural compounds such as spermidine struggle to attract the research funding available to patentable drugs.

Daphna also pushes on the evidence. How much do we actually know about spermidine in humans? What can observational studies tell us — and what can they not? How does the evidence compare with interventions such as rapamycin? And when does an intriguing longevity molecule become something we can genuinely recommend?

The conversation expands beyond supplements into a broader discussion about personal responsibility for health, the exposome, the future of preventative medicine and what healthcare could look like if it focused not simply on extending life, but on helping people live well for longer — right through to the end.

Guest Bio

Leslie Kenny is the founder of Oxford Healthspan and co-founder of the Oxford Longevity Project. Diagnosed with rheumatoid arthritis and lupus at 39 and given a five-year prognosis, Kenny used patient research, dietary overhaul, and an experimental immunoglobulin therapy to reverse her condition into long-term remission. She trained at the Institute for Integrative Nutrition and now serves as Global Executive Ambassador for the Japan Autophagy Consortium. Through Oxford Healthspan, she develops food-derived spermidine and nettle-based nutraceuticals, and through the Oxford Longevity Project, she works alongside scientists including Sir Muir Gray, Sir Christopher Ball, Dr Paul Chen, and Emeritus Professor Dennis Noble to advance patient-centred ageing research.

LinkedIn: https://www.linkedin.com/in/leslie-kenny-oxford/

Timestamps

* 00:00 — Introduction to Leslie Kenny and her story

* 02:10 — IVF, autoimmune disease and the diagnosis that changed everything

* 04:30 — Questioning the original diagnosis and discovering a thyroid problem

* 08:15 — How patient research led Leslie to intravenous immunoglobulin (IVIG)

* 13:00 — Diet, elimination protocols and visualisation

* 17:40 — Reaching remission and turning personal experience into advocacy

* 21:50 — How to challenge your doctor without rejecting conventional medicine

* 25:30 — What spermidine is and why Leslie became interested in it

* 29:15 — Spermidine, the hallmarks of ageing and the comparison with rapamycin

* 34:00 — Why natural compounds can struggle for funding, patents and attention

* 38:20 — What the human evidence for spermidine actually tells us

* 43:10 — The funding problem in independent longevity research

* 45:30 — Oxford Healthspan and the Oxford Longevity Project

* 48:00 — How much control do we really have over our health and ageing?

* 52:00 — Rethinking hospitals, later life and what a good death looks like

* 56:30 — Rapid-fire questions

* 59:00 — Closing reflections

References & Further Reading

  • Kenny, L. — founder, Oxford Healthspan
  • Oxford Longevity Project (co-founded with Sir Muir Gray, Sir Christopher Ball, Dr. Paul Chen, Prof. Dennis Noble)
  • Sears, B. — The Anti-Aging Zone
  • Franceschi, C. — originator of the "inflammaging" concept
  • Partridge, L., Madeo, F., Kennedy, B. — research on spermidine and the hallmarks of ageing
  • Eisenberg, T., et al. — Grazer study on spermidine and human cell telomeres (2021)

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(31)

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy...

2 Aug 48min

Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

In this episode of Beyond Longevity, Daphna speaks with Dr Peter Scriven, Co-Founder and Clinical & Scientific Director of LONGEVITY, about what longevity medicine should actually look like: moving fr...

26 Juli 1h 2min

Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

In this episode of Beyond Longevity, Daphna speaks with Jody Tropeano Greene, Head of Content at HLTH, and Alexa Mikhail, Senior Content Lead at HLTH US, about how HLTH identifies the healthcare topic...

19 Juli 52min

From Blockbuster Medicine to Extending Healthspan with Sundeep Dugar PhD

From Blockbuster Medicine to Extending Healthspan with Sundeep Dugar PhD

On Beyond Longevity, host Daphna speaks with Dr Sundeep Dugar, PhD, co-founder of BlueOakNx and the scientists behind the blockbuster cholesterol medicines Zetia (ezetimibe) and Vytorin. He explains h...

12 Juli 59min

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Daphna sat down with Robert Gielow, founder of Mentry Pharma, to discuss what it really takes for foreign supplement and longevity companies to enter the pharmacy markets of Germany, Austria and Switz...

5 Juli 1h

AI, Ageing And The Question Of Trust with Dr Filippo Dall'Armellina

AI, Ageing And The Question Of Trust with Dr Filippo Dall'Armellina

Biology is undergoing one of the biggest transformations in its history. AI is helping researchers analyse enormous datasets, predict protein structures, identify drug targets, and accelerate scientif...

28 Juni 57min

Kyle Holbert on Heavy Metals, Missed Diagnoses and Making Longevity Medicine More Accessible

Kyle Holbert on Heavy Metals, Missed Diagnoses and Making Longevity Medicine More Accessible

Beyond Longevity interviews Kyle Holbert, COO and co-founder of Longevity Centres of America, about how unexplained fatigue, brain fog, depression, anxiety, joint pain and gut issues derailed his heal...

21 Juni 57min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
hacka-livet
ufo-sverige
rss-kriminologerna
svd-nyhetsartiklar
bildningspodden
rss-vetenskapsradion
halsorevolutionen
det-morka-psyket
rss-vetenskapsradion-2
sexet
ufo-sverige-2
medicinvetarna
vetenskapsradion
barnpsykologerna
paranormalt-med-caroline-giertz
rss-odla
rss-ufobortom-rimligt-tvivel